Abstract:A biosynthetic pathway was constructed to produce α‐aminoadipate. Multi‐strategy metabolic engineering was used for regulating cell metabolism. Finally, 1.54 g/L of α‐aminoadipate was produced in fed‐batch experiments. As a non‐protein amino acid, α‐aminoadipate is used in the fields of medicine, chemical engineering, food science, and others. For example, α‐aminoadipate is an important precursor for the production of β‐lactam antibiotics. Currently, the synthesis of α‐aminoadipate depends on chemical catalysis that has the disadvantages of high cost, low yield, and serious pollution. In this study, we construct a biosynthesis pathway of α‐aminoadipate in Escherichia coli using lysine as a precursor. In addition, we regulate the cell metabolism to improve the titer of α‐aminoadipate via multi‐strategy metabolic engineering. First, a novel synthetic pathway was constructed to realize de novo synthesis of α‐aminoadipate with titers of 82 mg/L. Second, the key enzymes involved in enhancing precursor synthesis were overexpressed and the CO2 fixation process was introduced, and these led to 80% and 34% increases in the α‐aminoadipate concentration, reaching 147 and 110 mg/L, respectively. Third, cofactor regulation was used to maintain the coupling balance of material and energy, with the intracellular α‐aminoadipate concentration reaching 140 mg/L. Fourth, the weakening of the synthesis of acetic acid was used to strengthen the synthesis of α‐aminoadipate, and this resulted in the enhancement of the α‐aminoadipate concentration by 2.2 times, reaching 263 mg/L. Finally, combination optimization was used to promote the production of α‐aminoadipate. The titers of α‐aminoadipate reached 368 mg/L (strain EcN11#) and 415 mg/L (strain EcN11##), which was 3.5 and 4 times higher than that of the parent strain. With these efforts, 1.54 g/L of α‐aminoadipate was produced under fed‐batch conditions by strain EcN11#. This study is the first to present the effective biosynthesis of α‐aminoadipate in E. coli using multi‐strategy metabolic engineering.

De Novo Biosynthesis of L-Azetidine-2-Carboxylic Acid in Escherichia Coli Strains for Powdery Mildew Treatment

Engineering Escherichia Coli for High-Yielding 2,5-Dimethylpyrazine Synthesis from L-Threonine by Reconstructing Metabolic Pathways and Enhancing Cofactors Regeneration

Metabolic Engineering of Escherichia coli for Production of 2,5-Dimethylpyrazine

Metabolic Engineering of Escherichia coli for De Novo Production of 1,5-Pentanediol from Glucose

Genetic Engineering of Escherichia Coli to Improve L-phenylalanine Production

De novo biosynthesis of α‐aminoadipate via multi‐strategy metabolic engineering in Escherichia coli

Balancing the AspC and AspA Pathways of Escherichia coli by Systematic Metabolic Engineering Strategy for High-Efficient l-Homoserine Production

Systems engineering of Escherichia coli for high-level glutarate production from glucose

Enhanced ε-Poly-L-Lysine Production in Streptomyces albulus through Multi-Omics-Guided Metabolic Engineering

Establishing biosynthetic pathway for the production of p-hydroxyacetophenone and its glucoside in Escherichia coli

Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate l-pipecolic acid in Escherichia coli

Metabolic Engineering of High L-Lysine-Producing Escherichia coli for de Novo Production of L-Lysine-Derived Compounds

Metabolic Engineering of Escherichia coli for the Biosynthesis of 3-Phenylpropionic Acid and 3-Phenylpropyl Acetate

Engineering Escherichia coli native metabolism for efficient biosynthesis of orotate

Engineering Escherichia coli BL21 (DE3) for high‐yield production of germacrene A, a precursor of β‐elemene via combinatorial metabolic engineering strategies

[Efficient biosynthesis of guanidoacetic acid by a recombinant strain of Bacillus subtilis]

Remodeling Metabolism of Corynebacterium Glutamicum for High-Level Dencichine Production

An Artificial Pathway for N-Hydroxy-Pipecolic Acid Production From L-Lysine in Escherichia coli

Metabolic Engineering of Escherichia coli for High-Level Production of l-Phenylalanine

Metabolic engineering of Escherichia coli for the production of phenylpyruvate derivatives

Engineering industrial fungus Aspergillus oryzae for sustainable biosynthesis of ergot alkaloids